Application 020599

Type
NDA
Sponsor
COVIS PHARMA BV

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001RILUTEKRILUZOLETABLET;ORAL50MGYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
64980-191RiluzoleriluzoleRising Pharmaceuticals, Inc.NDA AUTHORIZED GENERICCurrent
70515-700RilutekriluzoleCovis PharmaNDACurrent
70515-700RilutekriluzoleCovis Pharma US, IncNDACurrent
70515-700RilutekriluzoleCovis Pharma US, IncNDACurrent
70515-700RilutekriluzoleCovis PharmaNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
83349SUPPL 2025-09-12
83342SUPPL 2025-09-12
83341SUPPL 2025-09-12
62943SUPPL2020-05-13
62918SUPPL2020-05-12
57674ORIG2019-02-15
34937SUPPL2016-04-12
2842SUPPL2016-04-11
20756SUPPL2016-02-02
20755SUPPL2016-02-02
41466SUPPL2015-07-20
41465SUPPL2015-07-20
41468SUPPL2015-03-10
41467SUPPL2015-03-10
20757SUPPL2015-03-10
25291SUPPL2010-01-20
12820SUPPL2009-11-17
34936SUPPL2009-07-23
12819SUPPL2009-07-23
25290SUPPL2009-07-17
2841SUPPL2009-07-17
2840SUPPL2004-09-24
25289SUPPL2003-06-08
2839SUPPL2003-06-08
2838SUPPL2003-06-08